Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU
Clinical trial NCT01999777 · COMPLETED
Trial details
- NCT number
- NCT01999777
- Sponsor
- UCB Biopharma S.P.R.L.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2015-08-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.